Patents by Inventor Lina Ma

Lina Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200231489
    Abstract: A glass pharmaceutical package having a glass composition of 68.00 mol % to 81.00 mol % SiO2, from 4.00 mol % to 11.00 mol % Al2O3, from 0.10 mol % to 16.00 mol % Li2O, from 0.10 mol % to 12.00 mol % Na2O, from 0.00 mol % to 5.00 mol % K2O, from 0.10 mol % to 8.00 mol % MgO, from 0.10 mol % to 5.00 mol % CaO, from 0.00 mol % to 0.20 mol % fining agent. The glass pharmaceutical package is delamination resistant, and has class 1 or class 2 chemical durability in acid, base, and water. The glass pharmaceutical package may have a surface compressive stress of at least 350 MPa.
    Type: Application
    Filed: April 1, 2020
    Publication date: July 23, 2020
    Applicant: CORNING INCORPORATED
    Inventors: Steven Edward DeMartino, Nadja Teresia Lönnroth, Lina Ma, Robert Anthony Schaut, Charlene Marie Smith, Zhongzhi Tang, Jamie Todd Westbrook
  • Publication number: 20200181001
    Abstract: Disclosed herein are glasses that present several advantages over traditional glass compositions used in optical applications. The glasses disclosed herein have a low devitrification tendency and can be processed by melt quenching and formed into macroscopic components. The glasses have high glass thermal stability indices and are chemically durable. The glasses disclosed herein are transparent when heat treated in air or oxygen and have high refractive indices and low density, as well, making them suitable for optical applications.
    Type: Application
    Filed: December 2, 2019
    Publication date: June 11, 2020
    Inventors: Bruce Gardiner Aitken, Lina Ma
  • Publication number: 20200182600
    Abstract: The present disclosure provides a blade inspection device, a method and a printing modification device, and belongs to the technical field of screen printing. The blade inspection device includes a telescopic component, a driving component and a parameter obtaining module. The driving component is configured to drive the telescopic component to move in a direction parallel to the line where the blade is located. The parameter obtaining module is configured to obtain a first parameter to inspect the blade according to the first parameter. The first parameter is related to a displacement of the first end of the telescopic component in a direction perpendicular to the line where the blade is located.
    Type: Application
    Filed: June 27, 2018
    Publication date: June 11, 2020
    Inventors: Lina Wang, Dawei Ma, Chunchieh Huang, Zifeng Wang
  • Patent number: 10676713
    Abstract: A borophosphate glass composition including B2O3, P2O5, and CaO, and optionally a source additive selected from: Li2O, Na2O, K2O, Al2O3, ZnO, MgO, Fe2O3/FeO, CuO/Cu2O, and mixtures thereof, as defined herein. Also disclosed are bioactive compositions or substrates including the disclosed borophosphate glass composition, and at least one live cell. Also disclosed are methods of inhibiting or increasing the relative amount of species containing boron, phosphorous, or both, being released into an aqueous solution from aborophosphate glass composition defined herein. Also disclosed is a method of proliferating cells on a bioactive substrate as defined herein. Also disclosed are related glass compositions that exclude one of B2O3, P2O5, and CaO.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: June 9, 2020
    Assignee: Corning Incorporated
    Inventors: Huayun Deng, Ye Fang, Qiang Fu, Aize Li, Lina Ma, John Christopher Mauro
  • Patent number: 10640415
    Abstract: A glass pharmaceutical package having a glass composition of 68.00 mol % to 81.00 mol % SiO2, from 4.00 mol % to 11.00 mol % Al2O3, from 0.10 mol % to 16.00 mol % Li2O, from 0.10 mol % to 12.00 mol % Na2O, from 0.00 mol % to 5.00 mol % K2O, from 0.10 mol % to 8.00 mol % MgO, from 0.10 mol % to 5.00 mol % CaO, from 0.00 mol % to 0.20 mol % fining agent. The glass pharmaceutical package is delamination resistant, and has class 1 or class 2 chemical durability in acid, base, and water. The glass pharmaceutical package may be substantially free of B2O3, SrO, BaO, and ZrO2.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: May 5, 2020
    Assignee: CORNING INCORPORATED
    Inventors: Steven Edward DeMartino, Nadja Teresia Lönnroth, Lina Ma, Robert Anthony Schaut, Charlene Marie Smith, Zhongzhi Tang, Jamie Todd Westbrook
  • Publication number: 20190218136
    Abstract: An optical boroaluminate glass article comprises: from greater than or equal to 10.0 mol % to less than or equal to 30.0 mol % Al2O3; from greater than or equal to 10.0 mol % to less than or equal to 55.0 mol % CaO; from greater than or equal to 10.0 mol % to less than or equal to 25.0 mol % B2O3; from greater than or equal to 0.0 mol % to less than or equal to 30.0 mol % SiO2; and from greater than or equal to 1.0 mol % to less than or equal to 20.0 mol % refractive index raising components. The optical boroaluminate glass article has a refractive index of the glass article, measured at 589.3 nm, of greater than or equal to 1.62, and a density of less than or equal to 4.00 g/cm3.
    Type: Application
    Filed: January 9, 2019
    Publication date: July 18, 2019
    Inventors: Bruce Gardiner Aitken, Lina Ma, John Christopher Mauro
  • Publication number: 20190218137
    Abstract: A borate glass includes from 25.0 mol % to 70.0 mol % B2O3; from 0.0 mol % to 10.0 mol % SiO2; from 0.0 mol % to 15.0 mol % Al2O3; from 3.0 mol % to 15.0 mol % Nb2O5; from 0.0 mol % to 12.0 mol % alkali metal oxides; from 0.0 mol % to 5.0 mol % ZnO; from 0.0 mol % to 8.0 mol % ZrO2; from 0.0 mol % to 15.0 mol % TiO2; less than 0.5 mol % Bi2O3; and less than 0.5 mol % P2O5. The optical borate glass includes a sum of B2O3+Al2O3+SiO2 from 35.0 mol % to 76.0 mol %, a sum of CaO+MgO from 0.0 mol % to 35.5 mol %. The borate glass has a refractive index, measured at 587.6 nm, of greater than 1.70, a density of less than 4.50 g/cm3, and an Abbe number, VD, from 20.0 to 47.0.
    Type: Application
    Filed: January 14, 2019
    Publication date: July 18, 2019
    Inventors: Xiaoju Guo, Lina Ma, Paulo Jorge Gaspar Marques, Zhongzhi Tang
  • Publication number: 20180147114
    Abstract: A glass pharmaceutical package having a glass composition of 68.00 mol % to 81.00 mol % SiO2, from 4.00 mol % to 11.00 mol % Al2O3, from 0.10 mol % to 16.00 mol % Li2O, from 0.10 mol % to 12.00 mol % Na2O, from 0.00 mol % to 5.00 mol % K2O, from 0.10 mol % to 8.00 mol % MgO, from 0.10 mol % to 5.00 mol % CaO, from 0.00 mol % to 0.20 mol % fining agent. The glass pharmaceutical package is delamination resistant, and has class 1 or class 2 chemical durability in acid, base, and water. The glass pharmaceutical package may be substantially free of B2O3, SrO, BaO, and ZrO2.
    Type: Application
    Filed: November 29, 2017
    Publication date: May 31, 2018
    Applicant: CORNING INCORPORATED
    Inventors: Steven Edward DeMartino, Nadja Teresia Lönnroth, Lina Ma, Robert Anthony Schaut, Charlene Marie Smith, Zhongzhi Tang, Jamie Todd Westbrook
  • Publication number: 20170349876
    Abstract: A borophosphate glass composition including B2O3, P2O5, and CaO, and optionally a source additive selected from: Li2O, Na2O, K2O, Al2O3, ZnO, MgO, Fe2O3/FeO, CuO/Cu2O, and mixtures thereof, as defined herein. Also disclosed are bioactive compositions or substrates including the disclosed borophosphate glass composition, and at least one live cell. Also disclosed are methods of inhibiting or increasing the relative amount of species containing boron, phosphorous, or both, being released into an aqueous solution from aborophosphate glass composition defined herein. Also disclosed is a method of proliferating cells on a bioactive substrate as defined herein. Also disclosed are related glass compositions that exclude one of B2O3, P2O5, and CaO.
    Type: Application
    Filed: May 23, 2017
    Publication date: December 7, 2017
    Inventors: Huayun Deng, Ye Fang, Qiang Fu, Aize Li, Lina Ma, John Christopher Mauro
  • Publication number: 20170340666
    Abstract: An aluminoborate composition, an alumino-borosilicate glass composition, or a mixture thereof, and solid or hollow microspheres thereof, as defined herein. Also disclosed are methods of making and using the disclosed compositions, for example, forming microspheres for use in bioactive applications, and composition extracts for use in treating or healing wounds.
    Type: Application
    Filed: May 23, 2017
    Publication date: November 30, 2017
    Inventors: Huayun Deng, Ye Fang, Qiang Fu, Lina Ma, John Christopher Mauro, Michael Joshua Snyder, Dana Lynne Widmer-Quiel